Literature DB >> 19124489

Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).

Sam Harper1, John Lynch, Stephen C Meersman, Nancy Breen, William W Davis, Marsha C Reichman.   

Abstract

BACKGROUND: Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among women in the United States and varies systematically by race-ethnicity and socioeconomic status. Previous research has often focused on disparities between particular groups, but few studies have summarized disparities across multiple subgroups defined by race-ethnic and socioeconomic position.
METHODS: Data on breast cancer incidence, stage, mortality, and 5-year cause-specific probability of death (100 - survival) were obtained from the Surveillance, Epidemiology, and End Results program and data on mammography screening from the National Health Interview Survey from 1987 to 2005. We used four area-socioeconomic groups based on the percentage of poverty in the county of residence (<10, 10-15, 15-20, +20%) and five race-ethnic groups (White, Black, Asian, American Indian, and Hispanic). We used summary measures of disparity based on both rate differences and rate ratios.
RESULTS: From 1987 to 2004, area-socioeconomic disparities declined by 20% to 30% for incidence, stage at diagnosis, and 5-year cause-specific probability of death, and by roughly 100% for mortality, whether measured on the absolute or relative scale. In contrast, relative area-socioeconomic disparities in mammography use increased by 161%. Absolute race-ethnic disparities declined across all outcomes, with the largest reduction for mammography (56% decline). Relative race-ethnic disparities for mortality and 5-year cause-specific probability of death increased by 24% and 17%, respectively.
CONCLUSIONS: Our analysis suggests progress towards race-ethnic and area-socioeconomic disparity goals for breast cancer, especially when measured on the absolute scale. However, greater progress is needed to address increasing relative socioeconomic disparities in mammography and race-ethnic disparities in mortality and 5-year cause-specific probability of death.

Entities:  

Mesh:

Year:  2009        PMID: 19124489     DOI: 10.1158/1055-9965.EPI-08-0679

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  91 in total

1.  Implicit value judgments in the measurement of health inequalities.

Authors:  Sam Harper; Nicholas B King; Stephen C Meersman; Marsha E Reichman; Nancy Breen; John Lynch
Journal:  Milbank Q       Date:  2010-03       Impact factor: 4.911

2.  Cancer control needs of 2-1-1 callers in Missouri, North Carolina, Texas, and Washington.

Authors:  Jason Q Purnell; Matthew W Kreuter; Katherine S Eddens; Kurt M Ribisl; Peggy Hannon; Rebecca S Williams; Maria E Fernandez; David Jobe; Susan Gemmel; Marti Morris; Debbie Fagin
Journal:  J Health Care Poor Underserved       Date:  2012-05

3.  Disparities in breast cancer characteristics and outcomes by race/ethnicity.

Authors:  Siew Loon Ooi; Maria Elena Martinez; Christopher I Li
Journal:  Breast Cancer Res Treat       Date:  2010-10-07       Impact factor: 4.872

4.  Racial and socio-economic disparities in breast cancer hospitalization outcomes by insurance status.

Authors:  Tomi Akinyemiju; Swati Sakhuja; Neomi Vin-Raviv
Journal:  Cancer Epidemiol       Date:  2016-07-07       Impact factor: 2.984

5.  Breast Cancer Incidence by Stage Before and After Change in Screening Guidelines.

Authors:  Fangjian Guo; Yong-Fang Kuo; Abbey B Berenson
Journal:  Am J Prev Med       Date:  2019-01       Impact factor: 5.043

6.  Healthy lifestyle impact on breast cancer-specific and all-cause mortality.

Authors:  Adaline E Heitz; Richard N Baumgartner; Kathy B Baumgartner; Stephanie D Boone
Journal:  Breast Cancer Res Treat       Date:  2017-08-31       Impact factor: 4.872

Review 7.  Population and target considerations for triple-negative breast cancer clinical trials.

Authors:  Terry Hyslop; Yvonne Michael; Tiffany Avery; Hallgeir Rui
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

8.  A comparative analysis of breast cancer stage between women enrolled in the National Breast and Cervical Cancer Early Detection Program and women not participating in the program.

Authors:  Manxia Wu; Harland Austin; Christie R Eheman; Zachary Myles; Jacqueline Miller; Janet Royalty; A Blythe Ryerson
Journal:  Cancer Causes Control       Date:  2015-03-12       Impact factor: 2.506

9.  Temporal trends in area socioeconomic disparities in breast-cancer incidence and mortality, 1988-2005.

Authors:  Mario Schootman; Min Lian; Anjali D Deshpande; Elizabeth A Baker; Sandi L Pruitt; Rebecca Aft; Donna B Jeffe
Journal:  Breast Cancer Res Treat       Date:  2010-01-07       Impact factor: 4.872

10.  Breast cancer treatment and ethnicity in British Columbia, Canada.

Authors:  Parvin Yavari; Maria Cristina Barroetavena; T Greg Hislop; Chris D Bajdik
Journal:  BMC Cancer       Date:  2010-04-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.